Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

SEASPINE HOLDINGS CORPORATION

(SPNE)
  Report
Real-time Estimate Cboe BZX  -  02:24 2022-09-26 pm EDT
5.665 USD   -2.33%
09/15SeaSpine to Present at the 2022 Ladenburg Thalmann Healthcare Conference
AQ
09/06SeaSpine Announces Full Commercial Launch of the WaveForm® TA (TLIF Articulating) Interbody System
AQ
09/06SeaSpine Holdings Corporation Announces Full Commercial Launch of the Waveform® Ta (Tlif Articulating) Interbody System
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

SeaSpine : Corporate Presentation August 2022

08/02/2022 | 04:43pm EDT

Operate in the Now

August 2, 2022

©2022 SeaSpine Orthopedics Corporation. All rights reserved | 1

Forward-looking Statements & Disclaimer

This presentation includes statements that may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "estimate," "expect," "anticipate," "project," "forecast" and similar expressions, or the negative thereof, among others, generally identify forward-looking statements. Forward- looking statements used in this presentation include revenue guidance; future revenue and revenue growth; liquidity to fund growth; new product launches and market opportunity, market share and market share growth. SeaSpine® cautions that these forward-looking statements are based on management's current expectations, estimates, forecasts and projections, and assumptions management believes are reasonable, and are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Such risks and uncertainties include, but are not limited to, the ongoing impact of the COVID-19 pandemic on the elective surgery market and the global healthcare system generally; risks that the COVID-19 pandemic may disrupt the Company's business and/or the global healthcare system more severely than anticipated; surgeons' willingness to use the Company's existing and newly launched products; the Company's ability to continue to invest in medical education and training, product development, and/or sales and marketing initiatives at levels sufficient to drive future revenue growth; the Company's ability to attract new, high-quality distributors and potential disruption to the Company's existing distribution network; continued pricing pressure, as well as exclusion from major healthcare systems; the risk of supply shortages and the associated, potentially long-term disruption to product sales; unexpected expense and delay; changes to laws and regulations applicable to the Company and the industry in which it competes; and general economic and business conditions in the markets in which the Company does business, both in the U.S. and abroad. Additional information about the factors that may affect the operations of SeaSpine and results is set forth in SeaSpine's annual and quarterly reports filed with the U.S. Securities and Exchange Commission. Forward-looking statements contained in this presentation are made only as of the date set forth on the cover hereof and SeaSpine undertakes no obligation to release publicly any revisions or updates to forward-looking statements as a result of subsequent events or developments, except as required by law.

©2022 SeaSpine Orthopedics Corporation. All rights reserved | 2

Sea Beyond

SeaSpine® is uniquely transforming the OR with safe, fast, real-time solutions that give surgeons & hospital partners

confidence and deliver better outcomes to improve patient lives - NOW.

©2022 SeaSpine Orthopedics Corporation. All rights reserved | 3

Transformative

Solutions

at Every Level.

In Real-time -

Operate

in the Now.

©2022 SeaSpine Orthopedics Corporation. All rights reserved | 4

7D Surgical Navigation

Unique Value Proposition

Leading the charge in accuracy,

safety and hospital economic benefit

FLASH™

SEGMENTAL

RADIATION-

SURGEON

FLEXIBLE

REGISTRATION

REGISTRATION

FREE FOR OPEN

CONTROL

PURCHASE

PROCEDURES

OPTIONS

©2022 SeaSpine Orthopedics Corporation. All rights reserved | 5

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

SeaSpine Holdings Corporation published this content on 02 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 August 2022 20:39:27 UTC.


© Publicnow 2022
All news about SEASPINE HOLDINGS CORPORATION
09/15SeaSpine to Present at the 2022 Ladenburg Thalmann Healthcare Conference
AQ
09/06SeaSpine Announces Full Commercial Launch of the WaveForm® TA (TLIF Articulating) Inter..
AQ
09/06SeaSpine Holdings Corporation Announces Full Commercial Launch of the Waveform® Ta (Tli..
CI
08/18SeaSpine to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
AQ
08/04SEASPINE HOLDINGS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
08/03Piper Sandler Adjusts Price Target on SeaSpine Holdings to $12 From $21, Reiterates Ove..
MT
08/02Seaspine : Q2 Earnings Snapshot
AQ
08/02Seaspine : Corporate Presentation August 2022
PU
08/02Transcript : SeaSpine Holdings Corporation, Q2 2022 Earnings Call, Aug 02, 20..
CI
08/02Seaspine : Reports 19% Revenue Growth and Record Quarterly Revenue for Second Quarter 2022..
PU
More news
Analyst Recommendations on SEASPINE HOLDINGS CORPORATION
More recommendations
Financials (USD)
Sales 2022 235 M - -
Net income 2022 -53,9 M - -
Net Debt 2022 - - -
P/E ratio 2022 -3,95x
Yield 2022 -
Capitalization 216 M 216 M -
Capi. / Sales 2022 0,92x
Capi. / Sales 2023 0,83x
Nbr of Employees 523
Free-Float 89,9%
Chart SEASPINE HOLDINGS CORPORATION
Duration : Period :
SeaSpine Holdings Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SEASPINE HOLDINGS CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 5,80 $
Average target price 18,28 $
Spread / Average Target 215%
EPS Revisions
Managers and Directors
Keith C. Valentine President, Chief Executive Officer & Director
John J. Bostjancic Chief Operating & Financial Officer
Kirtley C. Stephenson Non-Executive Chairman
Frank Vizesi Chief Scientific Officer
Stuart M. Essig Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SEASPINE HOLDINGS CORPORATION-57.42%216
STRYKER CORPORATION-22.62%78 286
SMITH & NEPHEW PLC-22.34%9 549
INSPIRE MEDICAL SYSTEMS, INC.-25.42%4 940
AXONICS, INC.16.50%3 205
GLAUKOS CORPORATION13.39%2 397